Celldex Therapeutics (CLDX) Gross Margin (QoQ) (2010 - 2026)
Celldex Therapeutics (CLDX) Gross Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Celldex Therapeutics |
2.16 Bn |
2.16 Bn |
-1.44 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-870,512.00 |
| Jun 30, 2025 |
10,044.00 |
| Mar 31, 2025 |
-17,458.00 |
| Dec 31, 2024 |
-10,370.00 |
| Sep 30, 2024 |
3,099.00 |
| Jun 30, 2024 |
77,381.00 |
| Dec 31, 2013 |
0.00 |
| Sep 30, 2013 |
0.00 |
| Jun 30, 2013 |
9,669.00 |
| Mar 31, 2013 |
68.00 |
| Dec 31, 2012 |
-80.00 |
| Sep 30, 2012 |
-333.00 |
| Jun 30, 2012 |
311.00 |
| Mar 31, 2012 |
58.00 |
| Dec 31, 2011 |
118.00 |
| Sep 30, 2011 |
134.00 |
| Jun 30, 2011 |
1.00 |
| Mar 31, 2011 |
-8,142.00 |
| Dec 31, 2010 |
3,255.00 |
| Sep 30, 2010 |
811.00 |
